Docoh
Loading...

Fri. 10 Sep 2021, 7:51am ETBenzinga
In: Small Cap, Media

On CNBC's "Mad Money Lightning Round," Jim Cramer said he isn't happy with the way Inseego Corp (NASDAQ:INSG) acts. He is beginning to believe it deserves to be trading 45% lower.

Biohaven Pharmaceutical Holding Co Ltd (NYSE:BHVN) is instrumental, said Cramer. He likes its drug Nurtec.

Cramer is not a buyer of Service Corporation International (NYSE:SCI). He said there are ways to make COVID-19 less life-threatening than the last year.

Cramer is astonished at how much Vertex Pharmaceuticals (NASDAQ:VRTX) has fallen given its cystic fibrosis franchise. He wouldn't sell it at its current price.